What is left of the THM? News and outlook
DOI:
https://doi.org/10.54695/rhh.26.01.4260Keywords:
Hormone treatment for the menopause, Gynecological cancers, Colon cancer, Venous thrombo-embolic disease.Abstract
Recently published studies have made it possible to
specify the risks of cancer and venous thromboembolic disease with the use of hormone replacement therapy for the menopause. These risks
appear to be variable depending on the method of
treatment applied and the types of oestrogens and
progesterone used.
Published
2013-03-01
Issue
Section
Articles
